Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Argo Group (ARGO) downgraded to Market Perform from Outperform at William Blair with analyst Adam Klauber citing a lower earnings outlook following the company's Q3 results. 2. RA Pharmaceuticals (RARX) was downgraded to Hold from Buy at Stifel and to Neutral from Buy at Guggenheim. 3. Newtek Business (NEWT) downgraded to Market Perform from Outperform at Raymond James with analyst Robert Dodd saying he believes the current valuation reflects a positive outlook, while loan growth indicators have declined. 4. Gap (GPS) downgraded to Market Perform from Outperform at Telsey Advisory. 5. Albemarle (ALB) downgraded to Underweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying Albemarle, currently trading at 11.2 times estimated EBITDA for 2020, is overvalued. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.